IS5931A - Use of small virus coatings to inhibit cell proliferation and cell migration - Google Patents

Use of small virus coatings to inhibit cell proliferation and cell migration

Info

Publication number
IS5931A
IS5931A IS5931A IS5931A IS5931A IS 5931 A IS5931 A IS 5931A IS 5931 A IS5931 A IS 5931A IS 5931 A IS5931 A IS 5931A IS 5931 A IS5931 A IS 5931A
Authority
IS
Iceland
Prior art keywords
small virus
cell proliferation
coatings
cell migration
inhibit
Prior art date
Application number
IS5931A
Other languages
Icelandic (is)
Inventor
Broliden Kristina
Westgren Magnus
Original Assignee
Broliden Kristina
Westgren Magnus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Broliden Kristina, Westgren Magnus filed Critical Broliden Kristina
Publication of IS5931A publication Critical patent/IS5931A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IS5931A 1998-11-24 2001-05-02 Use of small virus coatings to inhibit cell proliferation and cell migration IS5931A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804022A SE520177C2 (en) 1998-11-24 1998-11-24 Use of empty, non-infectious, recombinant parvoviral capsid particles, or β-antigen-blocking portions thereof, for the manufacture of drugs for inhibiting hematopoietic stem cells
PCT/IB1999/002112 WO2000030668A2 (en) 1998-11-24 1999-11-23 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration

Publications (1)

Publication Number Publication Date
IS5931A true IS5931A (en) 2001-05-02

Family

ID=20413393

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5931A IS5931A (en) 1998-11-24 2001-05-02 Use of small virus coatings to inhibit cell proliferation and cell migration

Country Status (14)

Country Link
EP (1) EP1131085A2 (en)
JP (1) JP2003516927A (en)
KR (1) KR20010080518A (en)
CN (1) CN1328469A (en)
AU (1) AU2566600A (en)
CA (1) CA2352043A1 (en)
CZ (1) CZ20011369A3 (en)
HU (1) HUP0104298A2 (en)
IS (1) IS5931A (en)
MX (1) MXPA01004949A (en)
NO (1) NO20012534L (en)
PL (1) PL348640A1 (en)
SE (1) SE520177C2 (en)
WO (1) WO2000030668A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124523T2 (en) 2001-07-10 2007-09-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Composition of a parvovirus VP1 protein variant and an arvovirus NS1 protein to induce cytolysis
EP1791858B1 (en) * 2004-09-24 2010-04-21 Intercell AG Modified vp1-capsid protein of parvovirus b19
CN101475942B (en) * 2008-11-28 2012-05-23 中国人民解放军第四军医大学 B19 virus VP1 unique region gene
US9598468B2 (en) 2011-05-18 2017-03-21 University Of Florida Research Foundation, Incorporated Polypeptides and vectors for targeting HER2/neu expressing cells and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002839C (en) * 1988-11-14 2000-10-10 Neal S. Young Parvovirus capsids
NL8902301A (en) * 1989-09-14 1991-04-02 Rijksuniversiteit HUMAN PARVOVIRUS B19 PROTEINS, THEIR PRODUCTION AND THEIR USE IN DIAGNOSTIC ASSAYS AND VACCINES.

Also Published As

Publication number Publication date
CZ20011369A3 (en) 2001-10-17
JP2003516927A (en) 2003-05-20
WO2000030668A3 (en) 2000-11-09
AU2566600A (en) 2000-06-13
CA2352043A1 (en) 2000-06-02
NO20012534L (en) 2001-06-29
WO2000030668A9 (en) 2001-04-05
PL348640A1 (en) 2002-06-03
CN1328469A (en) 2001-12-26
EP1131085A2 (en) 2001-09-12
KR20010080518A (en) 2001-08-22
SE9804022L (en) 2000-05-25
WO2000030668A8 (en) 2000-09-14
HUP0104298A2 (en) 2002-03-28
NO20012534D0 (en) 2001-05-23
SE520177C2 (en) 2003-06-03
WO2000030668A2 (en) 2000-06-02
SE9804022D0 (en) 1998-11-24
MXPA01004949A (en) 2003-03-10

Similar Documents

Publication Publication Date Title
EE200000706A (en) Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cell proliferation
DE69930647D1 (en) STRUCTURE ANALOGUE OF AMIN-BASES AND NUCLEOSIDES
NO20001323D0 (en) Dipeptide-apoptosis inhibitors and their use
DE69924589D1 (en) Single-phase silicone and water composition
DK0810415T3 (en) Ceramic armor plate and method of manufacture thereof
DK383989A (en) Means to counteract the formation of coatings and its use
NO20005100L (en) Genetically Modified Cells and Methods for Expression of Recombinant Heparanase and Methods for Purification of the Same
DK349486D0 (en) 4-SUBSTITUTED 2-AMINO-5-HYDROXYPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATMENT OF PULMONAL, ALLERGIC, INFLAMMATORY AND CARDIOVASCULAR DISEASES
DE59902868D1 (en) USE OF ECTOIN OR ECTOIN DERIVATIVES IN FORMULATIONS
DE69932024D1 (en) Retroactively controlled electrochemical detachment of gas turbine coatings
DE69827942D1 (en) LEPTIN AS INHIBITOR OF TUMOR CELL PROLIFERATION
DK0915872T3 (en) Substituted bisindolylmaleimides to inhibit cell proliferation
DK0898566T3 (en) Substituted benzylamines and their use in the treatment of depression
NO20014768D0 (en) Inhibitors of LFA-1 binding to ICAM and its uses
FI971934A7 (en) Acylated benzyl glycosides as inhibitors of smooth muscle cell proliferation
EP1039897A4 (en) INADON AND TETRALON COMPOUNDS TO INHIBIT CELL PROLIFERATION
DK1064279T3 (en) Substituted bisindolylmaleimides to inhibit cell proliferation
KR950703064A (en) Inhibitors of cell proliferation, methods of manufacturing and using them
DE69738735D1 (en) MIXTURES OF INTERPOLYMERS OF ALPHA-OLEFIN / VINYLIDENAROMATIC MONOMERS AND / OR DISABLED ALIPHATIC MONOMERS OR VINYLIDENCYCLOALIPHATIC MONOMERS
FI971936L (en) Smooth muscle cell proliferation inhibitors
EE03871B1 (en) Cyanoguanidines as inhibitors of cell proliferation
DE69737017D1 (en) USE OF ENERGY BURSTS IN CORDLESS NETWORKS
NO984156L (en) Coating of porous se electrodes with thin electrodes
ATE341156T1 (en) NUMBERING OF VIDEO OBJECTS AND CELLS
DE69838482D1 (en) IMPROVEMENTS FROM OR RELATED TO TELECOMMUNICATIONS